Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BrightSpring Health Raises FY2025 Sales Guidance from $12.00B-$12.50B to $12.20B-$12.60B vs $12.35B Est

Author: Benzinga Newsdesk | August 01, 2025 06:03am
BrightSpring Health (NASDAQ:BTSG) raises FY2025 sales outlook from $12.00 billion-$12.50 billion to $12.20 billion-$12.60 billion vs $12.35 billion estimate.

Posted In: BTSG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist